Victorian healthtech startups go-to-market in the USA
30 October 2019 Five Victorian medical device startups are better placed to take on the world after visiting Minnesota for the final Masterclass of BioMelbourne Network’s 2019 Healthtech Reimbursement program. Go-To-Market in the USA was a three-day experiential…
Takeda Pharmaceuticals and BioCurate announce collaboration to accelerate innovative early stage discoveries of new therapeutics and drugs
30 October 2019 Melbourne – BioCurate, a joint venture between Monash University and The University of Melbourne with support from the Victorian State Government, has signed an agreement with Takeda Pharmaceutical Company Limited (Takeda) to share commercial and…
AD-214 safe in non-human primates, bulk manufacturing complete
29 October 2019 MELBOURNE Australia: AdAlta Limited (ASX: 1AD), the biotechnology company advancing its lead i-body candidate towards clinical development, is pleased to announce the completion of its non-human primate study program necessary to enable the phase I…
Former Cochlear CEO Dr. Chris Roberts AO joins Atmo Biosciences Board
29 October 2019 Melbourne, Australia Former Cochlear Chief Executive Officer Dr. Chris Roberts AO has been appointed as a Non-Executive Director to the Board of Atmo Biosciences, a digital health business commercializing a world-first ingestible gas-sensing capsule that…
What’s Holding Up Digital Pathology?
28 October 2019 By Richard Lash MD, and Caroline Popper MD For centuries, the basics of pathologic examination of human tissue under a microscope has essentially remained unchanged. The excitement about Digital Pathology (creating digital images of the…
Ransomware – A first-hand account
28 October 2019 By Dr Irving Hofman RYUK is a sophisticated cryptoware with ransom requests of the order of half a million US dollars. The healthcare sector in Australia has become a specific target. Recently, the Exigence cybersecurity…
Dimerix awarded second Innovation Connections Grant
23 October 2019 MELBOURNE, Australia: Dimerix Limited (ASX: DXB), a clinical-stage drug development company, announced today that it has been awarded a second Innovation Connections Grant, which is supported by the Australian Government’s Department of Industry, Innovation and…
Dr Jennifer Rosenthal Appointed Clarity Pharmaceuticals Director of Quality and Regulatory Affairs
23 October 2019 Sydney, Australia – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Dr Jennifer Rosenthal as Director of Quality and Regulatory Affairs. Jennifer has more…
SeerPharma Journal October 2019
24 October 2019 SeerPharma is excited to publish the final issue of our Journal for 2019. With articles on our activities with customers and attendance at major industry events in the APAC region. We hope you find something…
Have your say in defining national skills standards for pharmaceutical bioprocessing – national project identifying unique skills and standards
Define national skills standards for pharmaceutical bioprocessing Pharmaceutical bioprocessing techniques are now making it possible to treat some illnesses where no other treatments were previously available. At present there are no national units of competency available for this…
FDA grants Orphan Drug Designation for NNZ-2591 to treat Phelan-McDermid syndrome and Pitt Hopkins syndrome
16 October Melbourne, Australia: Neuren Pharmaceuticals (ASX: NEU) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Neuren’s NNZ-2591 for the treatment of each of Phelan-McDermid syndrome and Pitt Hopkins syndrome.…
CSIROscope: How do you mend a broken heart?
16 October 2019 By Ali Green Sunday was World Heart Day and we celebrated in true CSIRO style – with science and technology. In a world-first, a man in the US received a replacement heart valve. It was…
